NO163568C - Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.

Info

Publication number
NO163568C
NO163568C NO854522A NO854522A NO163568C NO 163568 C NO163568 C NO 163568C NO 854522 A NO854522 A NO 854522A NO 854522 A NO854522 A NO 854522A NO 163568 C NO163568 C NO 163568C
Authority
NO
Norway
Prior art keywords
acid derivatives
preparation
therapeutic active
analogy procedure
quinoloncarboxylic
Prior art date
Application number
NO854522A
Other languages
English (en)
Norwegian (no)
Other versions
NO854522L (no
NO163568B (no
Inventor
Tsutomu Irikura
Seigo Suzue
Keiji Hirai
Takayoshi Ishizaki
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of NO854522L publication Critical patent/NO854522L/no
Publication of NO163568B publication Critical patent/NO163568B/no
Publication of NO163568C publication Critical patent/NO163568C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Table Devices Or Equipment (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO854522A 1984-11-13 1985-11-12 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. NO163568C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59239124 1984-11-13

Publications (3)

Publication Number Publication Date
NO854522L NO854522L (no) 1986-05-14
NO163568B NO163568B (no) 1990-03-12
NO163568C true NO163568C (no) 1990-06-20

Family

ID=17040142

Family Applications (1)

Application Number Title Priority Date Filing Date
NO854522A NO163568C (no) 1984-11-13 1985-11-12 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.

Country Status (21)

Country Link
EP (1) EP0183129B1 (de)
JP (1) JPH0637490B2 (de)
KR (2) KR930004652B1 (de)
CN (1) CN1011587B (de)
AT (1) ATE45354T1 (de)
AU (1) AU591640B2 (de)
CA (2) CA1290338C (de)
DE (1) DE3572170D1 (de)
DK (1) DK173185B1 (de)
ES (2) ES8704929A1 (de)
FI (1) FI83219C (de)
GR (1) GR852758B (de)
HU (1) HU198471B (de)
IE (1) IE58356B1 (de)
IN (2) IN162769B (de)
MX (1) MX162894B (de)
NO (1) NO163568C (de)
NZ (1) NZ214156A (de)
PH (1) PH21007A (de)
PT (1) PT81476B (de)
ZA (1) ZA858699B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
IL77846A (en) * 1985-03-25 1989-08-15 Warner Lambert Co Process for the preparation of 7-amino-quinolin-4-oxy-3-carboxylic acid derivatives
JPS62108878A (ja) * 1985-11-05 1987-05-20 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体およびその製造方法
US4692454A (en) * 1986-02-03 1987-09-08 Warner-Lambert Company Opthalmic use of quinolone antibiotics
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
JPS63179856A (ja) * 1987-01-21 1988-07-23 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法並びにその中間体
EP0319906A3 (de) * 1987-12-11 1990-05-02 Dainippon Pharmaceutical Co., Ltd. Chinolinderivate, Verfahren zu ihrer Herstellung und sie enthaltendes antibakterielles Mittel
US5233091A (en) * 1988-06-21 1993-08-03 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
US4885386A (en) * 1988-10-28 1989-12-05 Warner-Lambert Company Process for the synthesis of 3-chloro-2,4,5-trifluorobenzoic acid
DE3918544A1 (de) * 1989-06-07 1990-12-13 Bayer Ag Verfahren zur herstellung von 7-(3-amino- sowie 3-amino-methyl-1-pyrrolidinyl)-3-chinolon- carbonsaeuren sowie -naphthyridoncarbonsaeuren
ES2018977A6 (es) * 1989-11-29 1991-05-16 Marga Investigacion Procedimiento de preparacion de n-ciclopropil-4-fluoroanilinas.
FR2673426B1 (fr) * 1991-03-01 1993-07-16 Bouchara Sa Nouvelles quinolones, leur procede de preparation et les compositions en refermant.
KR950014567B1 (ko) * 1991-08-01 1995-12-08 주식회사대웅제약 신규한 퀴놀론 카르복실산 유도체
CN1065802C (zh) * 1992-02-08 2001-05-16 大野家建 研磨机及其自动化装置
DK0688772T3 (da) * 1994-06-16 1999-11-01 Lg Chemical Ltd Quinolincarboxylsyrederivater med 7-(4-aminomethyl-3-oxim)-pyrrolidinsubstituenter og fremgangsmåde til deres fremstilling
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel

Also Published As

Publication number Publication date
ZA858699B (en) 1986-07-30
JPS61267573A (ja) 1986-11-27
IE852790L (en) 1986-05-13
HU198471B (en) 1989-10-30
AU4946185A (en) 1986-05-22
FI854445A0 (fi) 1985-11-12
FI83219B (fi) 1991-02-28
GR852758B (de) 1986-02-25
FI83219C (fi) 1991-06-10
IN162769B (de) 1988-07-09
NZ214156A (en) 1988-06-30
DK519985A (da) 1986-07-01
PT81476B (pt) 1987-11-11
KR860004025A (ko) 1986-06-16
KR930004652B1 (ko) 1993-06-02
DK173185B1 (da) 2000-03-06
ES548800A0 (es) 1987-04-16
ES557306A0 (es) 1988-04-01
EP0183129A1 (de) 1986-06-04
IN164295B (de) 1989-02-11
KR920006236B1 (ko) 1992-08-01
DK519985D0 (da) 1985-11-12
IE58356B1 (en) 1993-09-08
PH21007A (en) 1987-06-23
AU591640B2 (en) 1989-12-14
MX162894B (es) 1991-07-08
FI854445A (fi) 1986-05-14
ES8802148A1 (es) 1988-04-01
ATE45354T1 (de) 1989-08-15
HUT40101A (en) 1986-11-28
JPH0637490B2 (ja) 1994-05-18
NO854522L (no) 1986-05-14
KR860004049A (ko) 1986-06-16
ES8704929A1 (es) 1987-04-16
CA1290338C (en) 1991-10-08
CN1011587B (zh) 1991-02-13
CA1282412C (en) 1991-04-02
NO163568B (no) 1990-03-12
EP0183129B1 (de) 1989-08-09
DE3572170D1 (de) 1989-09-14
CN85109026A (zh) 1986-07-30
PT81476A (en) 1985-12-01

Similar Documents

Publication Publication Date Title
NO163568C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
NO166126C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
NO171785C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinazolinderivater
ES8606330A1 (es) Procedimiento para preparar derivados de acidos quinolincar-boxilicos
NO168418C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser
ES8606283A1 (es) Procedimiento para preparar derivados de acidos quinolon- carboxilicos
PT87005A (pt) Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents
GR3006108T3 (de)
ATE95697T1 (de) Uricosuretische zusammensetzung.
DE3782235D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.